Quarterly sales of arthroscopic devices reached $81 million, up from $70.6 million from the same quarter last year. Over the six-month period ending June 30, the company saw similar growth, from $146 million in 2011 to $167.2 million in 2012. This increase indicates a 14.5 percent increase.
More Articles on Orthopedic Devices:
CareFusion Reports $968M 4Q Revenue, Up 3%
8 Spine Device Company 2Q Financial Reports
Mazor Robotics Enters Into Agreement With Investors to Receive $15M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.